Taipei, Taiwan

You-Chia Yeh


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: You-Chia Yeh: Innovator in T-Cell Mediated Inflammatory Disease Treatment

Introduction

You-Chia Yeh is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of medical science, particularly in the treatment of T-cell mediated inflammatory diseases and cancers. His innovative approach combines the use of anti-PSGL-1 antibodies with JAK inhibitors, showcasing his commitment to advancing healthcare solutions.

Latest Patents

You-Chia Yeh holds a patent for "Methods of using anti-PSGL-1 antibodies in combination with JAK inhibitors to treat T-cell mediated inflammatory diseases or cancers." This patent outlines methods for treating or preventing T-cell mediated inflammatory diseases, such as acute or chronic graft-versus-host disease (GVHD), by administering a therapeutically effective amount of an antibody that specifically binds to human PSGL-1 alongside a Janus kinase (JAK) inhibitor.

Career Highlights

Throughout his career, You-Chia Yeh has been associated with Altrubio Inc., where he has been able to apply his expertise in immunology and therapeutic development. His work has been instrumental in creating innovative treatments that address critical health challenges.

Collaborations

You-Chia Yeh has collaborated with notable colleagues, including Shih-Yao Lin and Feng-Lin Chiang. These partnerships have fostered a collaborative environment that enhances research and development efforts in the field of immunotherapy.

Conclusion

You-Chia Yeh's contributions to the treatment of T-cell mediated inflammatory diseases highlight his role as a leading inventor in the medical field. His innovative patent and collaborative efforts continue to pave the way for advancements in healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…